Is BBI or DIVO a better dividend investment in 2026?

BBI currently yields 85.11% with a 5% 5-year dividend growth rate. DIVO yields 4.00% with 5% growth. The better choice depends on your goal: BBI offers higher current income.

What is the dividend yield difference between BBI and DIVO?

BBI has a forward dividend yield of 85.11% ($2.00/share annually). DIVO yields 4.00% ($2.00/share annually). The yield gap is 81.11 percentage points.

Home › Compare › BBI vs DIVO

BBI vs DIVO: Dividend Comparison 2026

BBI yields 85.11% · DIVO yields 4.00%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BBI wins by $2.05M in total portfolio value

INVESTMENT

TIME HORIZON10 years

BBI

● Live price

85.11%

Share price

$2.35

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2.08M

Annual income

$627,483.66

Full BBI calculator →

DIVO

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.0K

Annual income

$899.19

Full DIVO calculator →

Portfolio growth — BBI vs DIVO

📍 BBI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BBI	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BBI + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BBI pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BBI

Annual income on $10K today (after 15% tax)

$7,234.04/yr

After 10yr DRIP, annual income (after tax)

$533,361.11/yr

DIVO

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$764.31/yr

At 15% tax rate, BBI beats the other by $532,596.80/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BBI + DIVO for your $10,000?

BBI: 50%DIVO: 50%

100% DIVO50/50100% BBI

Portfolio after 10yr

$1.05M

Annual income

$314,191.43/yr

Blended yield

29.84%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on BBI right now

BBI

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

-7.2

Piotroski

4/9

DIVO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BBI buys

DIVO buys

No recent congressional trades found for BBI or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBBIDIVO

Forward yield	85.11% ✓	4.00%
Annual dividend / share	$2.00	$2.00
Payout ratio	50%	50%
1-year div growth	0%	5% ✓
5-year div CAGR	0%	5% ✓
Portfolio after 10y	$2.08M	$28.0K ✓
Annual income after 10y	$627,483.66 ✓	$899.19
Total dividends collected	$1.82M	$6.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: BBI vs DIVO ($10,000, DRIP)

Year	BBI Portfolio	BBI Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$19,211	$8,510.64	$11,120	$420.00	+$8.1K → BBI
2	$35,835	$15,279.89	$12,357	$458.31	+$23.5K → BBI
3	$64,982	$26,638.22	$13,721	$499.76	+$51.3K → BBI
4	$114,675	$45,144.37	$15,227	$544.58	+$99.4K → BBI
5	$197,158	$74,455.37	$16,885	$593.02	+$180.3K → BBI
6	$330,593	$119,634.65	$18,713	$645.34	+$311.9K → BBI
7	$541,214	$187,479.44	$20,724	$701.81	+$520.5K → BBI
8	$865,943	$286,843.50	$22,938	$762.73	+$843.0K → BBI
9	$1,355,484	$428,924.80	$25,372	$828.41	+$1.33M → BBI
10	$2,077,851	$627,483.66	$28,047	$899.19	+$2.05M → BBI

BBI vs DIVO: Complete Analysis 2026

BBI — Stock

Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. The company was founded in 2009 and is headquartered in Boulder, Colorado.

Full BBI Calculator →

DIVO — ETF

DIVO is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in DIVO shares.

Full DIVO Calculator →

📬

Get this BBI vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BBI vs SCHD BBI vs JEPI BBI vs O BBI vs KO BBI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.